Most sold healthcare stocks in Q4 2017

See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2017, measured as net reductions in reported share positions from Q3 2017 into Q4 2017. Notable reductions at the top of this list include IDEXX LABORATORIES INC (IDXX), BAXTER INTERNATIONAL INC (BAX), PFIZER INC (PFE), MCKESSON CORP (MCK). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
IDXXIDEXX LABORATORIES INC-13,798,458-$848.64K01203
BAXBAXTER INTERNATIONAL INC-5,385,767-$261.48K01408
PFEPFIZER INC-5,053,717-$42.20M147014
MCKMCKESSON CORP-3,651,010-$542.74K04226
MRKMERCK & CO. INC.-2,519,432$26.72M182113
EWEDWARDS LIFESCIENCES CORP-2,106,995-$218.29K11113
JNJJOHNSON & JOHNSON-1,645,023-$23.95M1211018
WBAWALGREENS BOOTS ALLIANCE INC-1,633,599-$1.69M11336
TDOCTELADOC HEALTH INC-1,535,967-$50.46K01102
ABBVABBVIE INC-1,428,803$32.55K02519
PDCOPATTERSON COS INC-1,426,918-$80.39K00313
HALOHALOZYME THERAPEUTICS INC-1,168,657-$4.47K11104
AMRNAMARIN CORP PLC -ADR-1,106,614-$2.73K00101
OPKOPKO HEALTH INC-917,500-$6.61K00101
ALNYALNYLAM PHARMACEUTICALS INC-908,776-$27.98K10203
PINCPREMIER INC-CLASS A-742,189-$27.39K01203
EXELEXELIXIS INC-716,700$1.65K00101
CTLTCATALENT INC-686,900-$25.68K00102
OSURORASURE TECHNOLOGIES INC-679,603-$29.86K00101
AZTAAZENTA INC-571,257-$17.41K00101
GRFSGRIFOLS SA-ADR-571,242-$3.00K00202
DHRDANAHER CORP-536,941$245.30K134110
UHSUNIVERSAL HEALTH SERVICES-B-500,932-$53.77K01102
THCTENET HEALTHCARE CORP-498,613-$8.19K00010
SYKSTRYKER CORP-488,760$48.83K01405
CNCCENTENE CORP-432,478-$37.53K10203
HUMHUMANA INC-418,400-$87.54K00101
HQYHEALTHEQUITY INC-324,500-$16.55K00011
UNHUNITEDHEALTH GROUP INC-298,678$1.16M1113016
CRLCHARLES RIVER LABORATORIES-279,757-$26.21K01203
GMEDGLOBUS MEDICAL INC - A-258,100-$2.88K00101
PETSPETMED EXPRESS INC-233,715$12.44K00101
SRNESORRENTO THERAPEUTICS INC-233,563-$24500011
CDXSCODEXIS INC-220,500-$64600101
VREXVAREX IMAGING CORP-211,061$10.25K01304
KURAKURA ONCOLOGY INC-177,106-$2.62K00101
INVAINNOVIVA INC-175,643-$2.28K01102
ADAPADAPTIMMUNE THERAPEUTICS-ADR-161,100-$2.82K00101
MMSIMERIT MEDICAL SYSTEMS INC-137,612-$5.83K00010
PBYIPUMA BIOTECHNOLOGY INC-134,600-$16.12K00010
MASIMASIMO CORP-131,300-$12.34K00101
SNYSANOFI-ADR-130,342-$457.97K00406
BIIBBIOGEN INC-116,198-$36.13K13115
USPHU.S. PHYSICAL THERAPY INC-113,700-$59100101
RGENREPLIGEN CORP-112,300-$4.40K00101
ICUIICU MEDICAL INC-110,300-$10.47K00101
VCELVERICEL CORP-104,792-$70900101
RDYDR. REDDY'S LABORATORIES-ADR-101,800-$3.45K00011
LMATLEMAITRE VASCULAR INC-95,600-$4.45K00101
BLUEBLUEBIRD BIO INC-91,869-$7.67K00111
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.−15.2M−11.4M−7.6M−3.8M0.00Net change in reported shares (all institutional filers)IDXXBAXPFEMCKMRKEWJNJWBATDOCABBVPDCOHALOAMRNOPKALNYPINCEXELCTLTOSURAZTASymbol

Frequently asked questions about Most sold healthcare stocks in Q4 2017

  • What are the most sold Healthcare stocks in Q4 2017?

    The most sold healthcare stocks in Q4 2017 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2017, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2017?

    Among filers in this sector, net reductions were largest in companies such as IDEXX LABORATORIES INC (IDXX), BAXTER INTERNATIONAL INC (BAX), PFIZER INC (PFE), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2017).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.